The promising role of new molecular biomarkers in prostate cancer: From coding and non-coding genes to artificial intelligence approaches

AP Alarcón-Zendejas, A Scavuzzo… - Prostate cancer and …, 2022 - nature.com
Background Risk stratification or progression in prostate cancer is performed with the
support of clinical-pathological data such as the sum of the Gleason score and serum levels …

Revealing the history and mystery of RNA-Seq

A Gondane, HM Itkonen - Current Issues in Molecular Biology, 2023 - mdpi.com
Advances in RNA-sequencing technologies have led to the development of intriguing
experimental setups, a massive accumulation of data, and high demand for tools to analyze …

ASF1B serves as a potential therapeutic target by influencing cell cycle and proliferation in hepatocellular carcinoma

X Ouyang, L Lv, Y Zhao, F Zhang, Q Hu, Z Li… - Frontiers in …, 2022 - frontiersin.org
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high
morbidity and mortality. Therefore, it is very important to find potential biomarkers that can …

Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities

S Araki, M Ohori, M Yugami - Frontiers in Oncology, 2023 - frontiersin.org
Accumulating evidence has indicated that pre-mRNA splicing plays critical roles in a variety
of physiological processes, including development of multiple diseases. In particular …

O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage

A Gondane, S Girmay, A Helevä, S Pallasaho… - Journal of biomedical …, 2022 - Springer
Background Transcription, metabolism and DNA damage response are tightly regulated to
preserve the genomic integrity, and O-GlcNAc transferase (OGT) is positioned to connect the …

CDK9 inhibition as an effective therapy for small cell lung cancer

L Valdez Capuccino, T Kleitke, B Szokol, L Svajda… - Cell Death & …, 2024 - nature.com
Abstract Treatment-naïve small cell lung cancer (SCLC) is typically susceptible to standard-
of-care chemotherapy consisting of cisplatin and etoposide recently combined with PD-L1 …

Targeting strategies for modulating pre-mRNA splicing with small molecules: recent advances

SJ Barraza, A Bhattacharyya, CR Trotta, MG Woll - Drug Discovery Today, 2023 - Elsevier
Highlights•Modulation of pre-mRNA splicing is an effective alternative to the direct targeting
of proteins.•Insight into pre-mRNA splicing biology offers practical targeted strategies to …

O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition

A Gondane, N Poulose, S Walker, IG Mills… - …, 2022 - academic.oup.com
Co-targeting of O-GlcNAc transferase (OGT) and the transcriptional kinase cyclin-dependent
kinase 9 (CDK9) is toxic to prostate cancer cells. As OGT is an essential glycosyltransferase …

Castration-resistant prostate cancer cells are dependent on the high activity of CDK7

S Pallasaho, A Gondane, A Kuivalainen… - Journal of Cancer …, 2023 - Springer
Purpose Prostate cancer (PC) is successfully treated with anti-androgens; however, a
significant proportion of patients develop resistance against this therapy. Anti-androgen …

Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium

JS Israel, LM Marcelin, C Thomas… - Journal of Experimental …, 2024 - Springer
Continued exploration of the androgen receptor (AR) is crucial, as it plays pivotal roles in
diverse diseases such as prostate cancer (PCa), serving as a significant therapeutic focus …